LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Mindray Showcases Comprehensive IVD Solutions Portfolio at MEDLAB Middle East 2020

By LabMedica International staff writers
Posted on 06 Feb 2020
Illustration
Illustration
Mindray (Shenzhen, China) showcased its range of in-vitro diagnostic products at MEDLAB 2020, including its CAL 6000 Cellular Analysis Line, SAL 9000 Modular System, CL-900i Chemiluminescence lmmunoassay System and BC-5150 Auto Hematology Analyzer.

Over 25,800 medical laboratory industry professionals and 600 exhibitors from 35 countries met in Dubai for MEDLAB Middle East, the Middle East & North Africa (MENA) region’s largest medical laboratory exhibition and congress, which took place from 3-6 February 2020 at the Dubai World Trade Centre.

At this year’s MEDLAB, Mindray showcased its CAL 6000 Cellular Analysis Line which combine two units of BC-6000 or BC-6200 auto hematology analyzers and one unit of SC-120 to deliver a throughput of up to 220 tests per hour and 120 slides per hour. The CAL 6000 is equipped with three loading platforms and three unloading platforms with large capacities. The bidirectional loading track, with patent technology, on the first hematology analyzer enables fast sample distribution, improving efficiency and productivity. Should the sample results trigger the criteria, the autoloader of each hematology analyzer will return the sample racks for automatic rerun or reflex check.

Mindray also presented its SAL 9000 Modular System which delivers high throughputs of chemistry and immunoassay testing by integrating its BS-2000 Chemistry Analyzer and CL-6000i Chemiluminescence Immunoassay Analyzer, and new Sample Processing System SPL 2000. With patented automatic serum analysis design, SAL 9000 helps optimize the management of lab space and manpower, and also offers highly reliable test results.

Additionally, Mindray showcased the CL-900i, one of the world’s smallest, fully automated chemiluminescence immunoassay analyzers, that integrates a large capacity and fast assay speed into a compact model, achieving a perfect balance between size and immunoassay testing performance. The CL-900i has a throughput of up to 180 tests/hour, and offers 50 sample positions and 15 reagent positions.

At MEDLAB Middle East, Mindray exhibited the BC-5150 Auto Hematology Analyzer which is especially tailored to assist diagnostic labs that need full CBC + 5-part results, with relatively low daily sample volume, restricted lab space and tight budget. As the lightest and most compact 5-part hematology analyzer so far from Mindray, BC-5150 is a highly user-friendly and innovative, offering cost-efficient CBC and 5-part white cell differential results.

Related Links:
Mindray

Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Automatic Hematology Analyzer
DH-800 Series

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more